Why Do People Cry During Ketamine Therapy?
Full Data ›
Full Explanation ›
Brain Science ›
Full Analysis ›
The Science ›
By Michael Alvear, Health Author & Independent Researcher
My research is published on these scholarly platforms:
Last Updated:
If you’re reading this, you probably cried during a ketamine session — maybe more than once, maybe with an intensity that surprised you, maybe without any idea why.
✓What you experienced is documented and expected
What you experienced is one of the most commonly reported effects in ketamine therapy, documented in the research and witnessed by practitioners in this field every single day.
The crying that may have frightened you is not a sign that something broke. It is a sign that something opened. You are not coming apart. You are coming back.
✍My experience — from a patient who went through it
I cried relentlessly during and after my first six ketamine sessions. Not politely. Not a few tears tracked down the side of my face. Relentless waves, each one rising and crashing harder than the last. I sobbed over things I could not name, over images and visions I could not explain, and often I had absolutely no idea why.
Here’s the thing. I’m not a guy who cries on the regular. In fact, I can only think of two or three times in my entire life where I broke down the way I did with ketamine therapy. The death of my older brother is one. So why did I cry so intensely — and relentlessly — during ketamine therapy?
For days afterward I felt like a human faucet — like someone had twisted a valve inside me and couldn’t find it to close it again. Every time the tears came, I’d think: What the hell is wrong with me?
I was embarrassed by it. I hid it when I could. I apologized when I couldn’t. Studies show ketamine can bring emotion forward before you have language for it. You are crying before you know what you are crying about. The ordinary managerial part of the mind — the part that edits, explains, contains, says not now — loses its grip. Feeling does not ask to be admitted. It enters.
When I started writing about ketamine therapy and heard from readers — I cried and I didn’t know why. Is that normal? Did I break something open that I can’t close? — I recognized the fear immediately. I’d had it myself.
ⓘAbout this page — and where the evidence stands
This page is my attempt to answer it properly. Built on peer-reviewed neuroscience, clinical data, practitioner accounts, and what I lived through personally. I’m not a clinician. I’m a patient who went through this, paid attention, and did the research.
One honest note on where the evidence stands: no study has made crying its direct research question. What we have is clinical observations, pharmacovigilance data, qualitative patient research, and a detailed body of mechanistic science on what ketamine does to the brain’s emotional architecture. Together, those things make the crying not just understandable — but in some ways, expected.
↪What happened next — and what I didn’t expect
For a long time, my first response to all of it was panic. Am I having a nervous breakdown? Am I coming apart at the seams? It took time — and honest work with my therapist — before I began to see it differently. The crying wasn’t evidence that something had gone wrong. It was part of what was going right. A necessary part.
By around my sixth session, the intensity had started to taper. It kept fading — less frequent, less overwhelming — until it was barely a factor anymore. Today I’m back to my usual self: not much of a crier. Though something got recalibrated that stayed recalibrated. I cry more easily now than I ever did before. Just not very often, and not very much.
But here is the thing I didn’t expect, and that I find genuinely strange to say: I almost miss it.
There was something in that intense, uncontrollable crying — a feeling of catharsis, of being alive, of feeling something with the full weight of my body — that I haven’t found anywhere else. I achieved remission through ketamine therapy, and I want to be clear: I do not miss the depression. Not a single second of it. But the crying itself? It was like watching a massive thunderstorm and then seeing the sun break through. Something clarifying. Something that, in the middle of all that panic and embarrassment, was quietly making me feel like myself again.
Ready for a deeper dive? We’ve organized everything you need to know into 14 comprehensive sections.
Click any card to jump directly to that section
How Common Is Crying During Ketamine Therapy?
More common than the published numbers suggest — and no, nobody is tracking it with the rigor it deserves.
What Clinical Studies Say About Crying During Ketamine Therapy
Here’s what the data shows. A 2023 clinical study by Su and colleagues documented crying in 14.3% of patients receiving IV ketamine infusions. A 2025 pharmacovigilance analysis of the FDA adverse event reporting database found that crying had a reporting odds ratio of 4.78 (95% CI 3.76–6.07) among patients receiving esketamine (Spravato) compared to non-esketamine antidepressants — meaning crying was reported at nearly five times the expected rate. That analysis covered 7,790 esketamine cases.
Those are real numbers. They’re also almost certainly undercounts, and significantly so.
Why Ketamine Clinical Trials Undercount Emotional Side Effects
Clinical trial data misses emotional responses for structural reasons. Trials are not designed to capture them — patients are rarely asked about crying directly, and emotional responses during infusions don’t fit neatly into the symptom checklists that trials use.
Pharmacovigilance data captures only what gets formally reported as an adverse event, which skews toward experiences that frightened someone enough to file a report. The patient who cried during their fourth infusion, felt it was profound and helpful, and went home — that experience doesn’t end up in the FAERS database.
Why Ketamine Patients Cry: What Qualitative Research Actually Found
The qualitative research gets closer. A 2025 meta-synthesis by Trimmel and colleagues, examining patient experience accounts across multiple ketamine studies, documented emotional and mood changes as a central reported experience, with emotionality often shifting toward greater positivity. A longitudinal qualitative study of twelve patients with treatment-resistant depression, following them through up to three sessions and multiple interviews, found emotional processing to be central to how patients described the experience over time. These studies weren’t counting tears. They were listening to patients describe what happened to them, and what patients described was often emotionally intense in ways that go undocumented in clinical trial records.
Ketamine Can Restore the Ability to Cry After Years of Emotional Numbness
One patient had not cried in twenty years. Across an entire six-session series, this patient’s eye mask was drenched at the end of every session. That’s not a side effect. That’s a person’s emotional system coming back online after two decades of shutdown.
— Clinical physician account from the published literature
I hear versions of this from readers regularly. People who describe themselves as stoic, or as someone who “just doesn’t cry,” finding themselves sobbing in ways they couldn’t control and didn’t expect. People who cried through an entire session and felt, afterward, something closer to relief than distress.
Why No Study Has Made Crying During Ketamine the Primary Research Question
The research gap is real and worth naming plainly: no study has made crying the primary research question. Given how routinely practitioners observe it and patients report it, that gap is striking. What we have instead is inference from clinical observations, pharmacovigilance signals, and a body of mechanistic research that makes the phenomenon clinically legible — even without a dedicated study.
Depression’s Emotional Lockdown — What Ketamine Is Undoing
Before you can understand why ketamine makes people cry, you need to understand what depression does to crying in the first place.
How Depression Kills the Ability to Cry — Not Just the Ability to Feel Happy
One of depression’s least-discussed features is that it takes away the capacity for emotional release. Not just the ability to feel pleasure — that’s the clinical term anhedonia, which most people have at least heard of. Depression also takes away grief, and tenderness, and the ability to be moved. People describe feeling behind glass. Present for their own life but not touching it. Something terrible happens and they feel nothing, or only a flat version of something that should be more. A piece of music that used to make them ache now just plays. A friend says something kind and it doesn’t land.
The inability to cry is common enough in depression that it shows up in clinical assessments — patients report it, and researchers have documented it. What it feels like from inside is a kind of emotional freeze: you know, abstractly, that you should be feeling something, and you can’t get to it.
SSRI Emotional Blunting: The Second Layer Suppressing Your Ability to Cry
Then add a second layer that many patients arriving at ketamine are carrying without fully naming it: SSRI-induced emotional blunting. This is distinct from depression’s own emotional suppression — it’s a medication effect, documented since the early 2000s, and it compounds what depression is already doing. Opbroek and colleagues, in a systematic study published in 2002, found that SSRI-treated patients showed significant suppression across multiple dimensions of emotional experience — including, specifically, the ability to cry. A qualitative study by Price, Cole, and Goodwin in 2009 found that emotional blunting from SSRIs was a “robust phenomenon” with demonstrable impact on how people functioned and whether they stayed on their medication.
Many patients in ketamine clinics today have been on SSRIs for years. Some for decades. They arrive carrying depression’s emotional freeze and a pharmacological suppression layered on top of it. Two separate mechanisms have been dampening the same system, in the same direction, for a long time.
How Ketamine Rapidly Reverses Emotional Numbness From Both Depression and SSRIs
Ketamine reverses both — rapidly, within hours of the first infusion. Its anti-anhedonic effect is documented and clinically meaningful: ketamine does not only reduce negative symptoms, it restores the capacity for positive emotional experience. At the same time, by bypassing the neurological architecture that depression and SSRIs have been reinforcing, it removes both suppressors at once.
What happens when a system that has been held under pressure for months or years suddenly has somewhere to go?
It goes. Often immediately. Often intensely. The crying is not a breakdown. It’s the first indication that the system is functional again. The more complete the freeze was, and the longer it lasted, the more there is that needs to move.
Why Crying During Ketamine Is Evidence of Healing, Not Breakdown
Patients describe this in terms that don’t sound clinical. Describing crying during ketamine, they’ll say things like: It was the first real thing I’d felt in years. Or: I didn’t even know I had that in me anymore. Or, more precisely and more painfully: I didn’t know I’d been that far gone until something started coming back.
That’s not a metaphor. That’s the anti-anhedonic effect working. The emotional material that had nowhere to go has found somewhere to go. The tears are the evidence of function returning — not proof that something has broken.
What Ketamine Is Actually Doing to Your Brain
There are four mechanisms doing most of the work. They don’t operate in sequence. They operate simultaneously, and they amplify each other.
If you’re going to understand why ketamine produces crying — especially crying you can’t explain — you need to understand what it’s actually doing neurologically. Not in the abstract. In the specific mechanics of how your brain processes emotion, and what changes when ketamine is in your system.
The amygdala is your brain’s primary emotional alarm system. It scans incoming information constantly — sensory data, memories, social cues — and flags what matters emotionally. In a healthy brain, it’s calibrated: reactive to genuine threat, quieter in the absence of it.
In depression, it’s miscalibrated in a specific and well-documented way: hyperreactive to negative stimuli, sluggish to positive ones. fMRI studies show depressed patients’ amygdalas firing excessively in response to negative emotional content and showing blunted responses to positive content. The alarm system is stuck on elevated sensitivity — and it’s stuck in the wrong direction, treating the world as more threatening and less rewarding than it is.
Ketamine recalibrates this. A 2019 NIMH study using double-blind placebo-controlled design found that ketamine normalized brain activity during emotional processing in patients with treatment-resistant depression. A separate study found that ketamine reduced amygdala-hippocampal reactivity during emotional stimulation, suggesting it was reducing the hyperreactivity rather than simply suppressing all emotional response. A Frontiers in Neuroscience study documented amygdala volume increases after six ketamine treatments — structural change, not just functional.
What does recalibration feel like? Emotional material that has been locked out starts moving differently. The alarm that kept firing falsely quiets. What replaces it is not blankness. It’s the opening of a channel that was jammed. When that channel opens, what has been backed up behind it moves. That movement is often experienced as tears.
The default mode network is the brain’s self-referential circuit — the system active when you’re thinking about yourself, reviewing the past, anticipating the future, or doing nothing in particular. In a healthy brain, the DMN activates and deactivates appropriately: it comes online during reflection, goes quiet during focused task engagement.
In depression, the DMN gets stuck. The circuit loops — rumination, negative self-evaluation, the same painful thoughts cycling without resolution. This is part of what people mean when they describe depression as a stuck record: the brain literally cannot stop playing it. The DMN hyperconnectivity is one of the most replicated findings in depression neuroscience.
Ketamine disrupts this. A 2012 study in PLOS ONE found that ketamine decreases resting-state functional network connectivity, with specific effects on the default mode network. A study published in Oxford’s Social Cognitive and Affective Neuroscience found ketamine-induced modulation of DMN connectivity, with meaningful effects on rumination. A more recent review documented that DMN, central executive network, and salience network alterations all shift with ketamine treatment.
What happens when the loop breaks? The self-referential mental weather clears, sometimes abruptly. What was underneath the rumination — what the loop was covering or containing — can surface. Patients describe this in different ways: a sudden absence of the usual noise, followed by something underneath it that they haven’t been able to access. That something is often emotional. And the emotion, suddenly having air, moves.
The prefrontal cortex is responsible, among many other things, for emotional regulation — the monitoring and management of emotional responses before they become fully expressed behavior. It’s why adults don’t burst into tears at a moving advertisement even when genuinely moved. The feeling arises; the prefrontal cortex assesses it, contextualizes it, and moderates how much of it shows.
In people who have spent years suppressing emotional expression — whether from cultural conditioning, personal history, or simply decades of depression — this gating mechanism is well-developed and routinely deployed. The stoic patient. The person who “just doesn’t cry.” What they have, in part, is a highly trained prefrontal inhibitor.
Ketamine partially suspends this. Neuroimaging research documents altered prefrontal functioning during ketamine administration, including reduced activity in the anterior cingulate cortex — a key node in emotional regulation. The emotional monitoring and suppression machinery is still present but operating at reduced capacity.
What this means practically: emotions that would normally be intercepted and managed before expression come through unfiltered. The person who has not cried in twenty years, whose eye mask is drenched at the end of every session — this is part of what is happening to them. The bypass they have developed over decades is temporarily offline. Whatever was being held behind it has nowhere to be held.
Note on Mechanism D — emotional memory rendered labile: The fourth mechanism — ketamine’s disruption of amygdala-hippocampal connectivity and its effect on emotional memory — is covered in detail in Section 4, where it directly explains why you can cry without knowing why.
Why Don’t I Know Why I’m Crying?
Ketamine can make the emotional soundtrack start playing before the movie appears. The feeling is real. The explanation isn’t accessible yet — and that is neurologically expected, not a sign something is wrong.
Sometimes, especially early on in my treatment, I would start crying in the middle of the journey for no apparent reason. There were no sad memories that surfaced, no imagery with any emotional charge, no visions or thoughts that could account for my upset.
It’s such a strange and confusing experience — how can you cry without knowing why? But I did. Often. It would break open in my chest with no narrative attached. I could not have told you what I was grieving. I did not even know if it was grief. It might have been relief. It might have been something that has no clean name in ordinary emotional life.
For a while, that absence of explanation unsettled me more than the crying itself. We are trained to interpret our emotions: find the cause, name the feeling, make the experience legible. When that fails, it can feel like there’s something wrong with you. Like the crying is evidence of damage.
It isn’t.
Why Ketamine Can Make You Cry Before You Know Why
The amygdala holds emotional charge. The hippocampus holds narrative — context, sequence, autobiographical memory. In ordinary emotional experience, these two structures work together. You feel grief, and the grief is attached to something: a loss, a memory, a thought sequence. The emotion and its story arrive together.
Ketamine disrupts the functional connection between the amygdala and hippocampus. What this means is that the emotional charge — the grief, the fear, the love — can become accessible while its narrative remains locked or unavailable.
Research from Yale’s Harpaz-Rotem and colleagues, studying ketamine’s effects in PTSD patients, documented decreased amygdala-hippocampus connectivity post-ketamine, with enhanced post-retrieval flexibility of emotional memory. Related work on memory reconsolidation shows that ketamine puts emotional memories in a labile state — capable of being accessed and potentially re-encoded, but during that access, the emotional content can surface separately from the contextual story.
Ketamine can make the emotional soundtrack start playing before the movie appears.
You can feel the full emotional force of the movie in your body. But the scene that explains it — the memory, the context, the name, the reason — has not come onscreen yet. That is why the crying can feel so real and so bewildering at the same time.
This is why you can be crying intensely and simultaneously unable to answer the question of what it’s about. The feeling is real. It’s just arriving without its label. The story, the explanation for the crying exists, somewhere in your nervous system, but the drug has disrupted the pathway that normally delivers feeling and story together as a package.
In other words, the feeling can arrive before the story does. You are not crying over nothing. You are feeling something real before your brain can explain it.
What I tell readers who describe this experience is simple: the absence of a story does not mean the absence of something real. Feeling before meaning is part of the ketamine experience for some people. The tears may be the first sign that your emotional system is working again after a long period of shutdown.
There is a particular version of this I hear from people who have lived with depression for years: the crying without knowing why feels more alive than anything they have felt in months. More like themselves than the flat non-feeling they had started to accept as normal.
How to Frame This With Your Therapist
One practical note for integration: when you bring this to a therapist, especially one unfamiliar with ketamine, don’t describe it only as “I cried and I don’t know why.” That can send the conversation in the wrong direction, toward diagnosis-hunting or forced interpretation.
A better frame to use
“My brain was processing emotional material before the story was available. The feeling was real. The explanation wasn’t accessible at the time. I want to work with what came up without forcing a meaning onto it too soon.”
The Intensity Spectrum — From a Few Tears to Uncontrollable Sobbing
Not everyone who cries during ketamine therapy cries the same way. The entire range is documented, expected, and normal. None of it predicts outcome better than any other.
Some people have mild tearfulness — eyes wet behind the eye mask, a few tears tracked down the side of their face. Some cry steadily through most of a session. Some sob — hard, full-body, the kind of crying that uses your whole chest — in waves that stop and start as the experience moves. And some cry from the moment the drug takes hold to the moment it releases them, without interruption.
The physician account from Section 1 — the patient who hadn’t cried in twenty years, eye mask drenched at the end of every session across a full six-session series — is the logical outcome of a particular set of circumstances converging. Understanding those circumstances explains the full range of intensity.
What Drives How Intense the Response Is
What intensity does not predict
Intense crying does not mean the treatment is working better. Mild tearfulness or no crying at all does not mean the session was therapeutically inert. The instinct to read intensity as signal is understandable and, based on current evidence, unsupported. What you’re observing is the magnitude of the emotional release, which is a function of all the factors above — not a dose-response curve for therapeutic benefit. The range is wide. The entire range is documented and expected. What matters is that the experience — whatever it looks like — is allowed to move.
The Role of Music and Set and Setting
Almost every ketamine session happens with music. This is not incidental. Music is a deliberate clinical choice — and its role goes well beyond background atmosphere.
Ketamine opens emotional access. Music, in that state, operates as an amplifier — directing what emotional territory gets accessed and influencing the intensity and character of what surfaces.
Music as a Therapeutically Active Agent — Not a Passive Backdrop
Music makes people cry without any drugs involved. That’s a documented finding: Mori and Iwanaga’s peer-reviewed research on peak emotional responses to music identified tears as a distinct and reproducible phenomenon, associated specifically with the experience of sadness, in contrast to chills, which tend to track with positive emotion. Music has the neurological infrastructure to produce emotional responses on its own. In the context of ketamine’s emotional openness — with the prefrontal gatekeeper stepped aside and the amygdala recalibrated and the DMN loop broken — that existing capacity is dramatically amplified.
The evidence for music as a therapeutically active agent in psychedelic and ketamine sessions, rather than a passive backdrop, is now solid enough to have its own literature. Kaelen and colleagues published what has become the foundational paper on this question: music experience significantly predicted reductions in depression one week after psilocybin administration, where general drug intensity did not. The drug opened the door; the music influenced what happened once you walked through it. A 2025 RCT found that music therapy during ketamine sessions decreased distress and supported emotional grounding. A 2025 peer-reviewed review affirmed music as a catalyst of emotion, connection, and transcendence across psychedelic-assisted therapy protocols.
Key finding — Kaelen et al.
Music experience significantly predicted reductions in depression one week after psilocybin administration — where general drug intensity did not. The drug opened the door; the music influenced what happened once you walked through it.
How Thoughtful Practitioners Actually Choose Music
What practitioners are actually doing — when they’re thoughtful about it — is choosing music that will guide rather than destabilize. The Osmind survey of clinicians working in ketamine and psychedelic therapy found broad practitioner consensus that music selection meaningfully shapes session outcomes.
This has a practical implication for patients: if a particular piece of music is making things worse — more destabilizing than opening, more frightening than cathartic — you can ask for it to be changed. That is a reasonable request. Providers who work in this space expect it.
Set and Setting — The Container That Shapes What Emerges
Beyond music, the broader set and setting of a ketamine session shapes what emotional material surfaces. “Set” refers to your mindset going in: your expectations, your intentions, your level of anxiety or preparation. “Setting” refers to the physical and social environment: the room, the lighting, whether a guide or provider is present and what their presence communicates.
These variables are real inputs, not soft periphery. The physical environment influences how safe it feels to let go. The presence of a trained guide communicates that whatever emerges can be witnessed and held. Pre-session intention setting — simply taking time before the infusion to acknowledge what you’re carrying or what you’re hoping for — has been incorporated into ketamine-assisted psychotherapy protocols for a reason: the brain, in its ketamine-opened state, tends to work with what it’s been given to work with.
None of this is about manufacturing a particular experience. It’s about creating the conditions under which whatever needs to emerge can emerge. The difference between a session where emotional material moves freely and one where it stays locked is often, in part, a function of how that container was constructed.
If you have any say in the setup of your sessions — in the music, in the environment, in whether a guide is present — it is worth using it. What you put into the room before the infusion begins shapes what the infusion finds.
Why Is It Still Happening Days After the Session?
The drug leaves your body within hours. What remains active is a neurobiological window that ketamine opens — and that stays open well after the ketamine itself is metabolized.
The drug leaves your body within hours. The ketamine high has cleared. You are at home, or at work, or driving to pick someone up — and then a piece of music plays, or someone says something kind, or nothing happens at all, and you are crying again. Or you wake up the next morning with emotions sitting right on the surface in a way they haven’t been in months. Or you cry every day for three or four days after the session, and then, gradually, you don’t.
This is not residual drug effect. The drug is gone. What is still active is something else: a neurobiological window that ketamine opens and that stays open well after the ketamine itself is metabolized. Understanding this changes how you relate to it — and how you use it.
The Neuroplasticity Window — What It Is and Why It Stays Open
Here’s what’s happening. Ketamine triggers the mTOR signaling pathway, which drives protein synthesis in neurons. That pathway activation produces a rapid increase in brain-derived neurotrophic factor — BDNF — the protein most associated with neural growth and synaptic flexibility. New synaptic connections form, and the brain’s capacity for emotional learning and reorganization is elevated above baseline. This is the neuroplasticity window: a period of heightened openness in which the brain is more capable of forming new emotional patterns than at almost any other time.
This is not a clinical metaphor. It is a documented biological phenomenon with a measurable timescale.
What This Means for Emotional Experience After the Session
What does this mean for emotional experience? The brain, during this window, is more permeable to emotional input than normal. Stimuli that would ordinarily register and pass through — a song, a kind word, something beautiful, an ordinary moment of human connection — land differently. They land with more weight. The emotional access that ketamine opened during the session hasn’t fully closed yet. Ordinary life is moving through a more open filter.
The neuroplasticity window is a resource.
The research on ketamine-assisted psychotherapy suggests that psychotherapy conducted during the neuroplasticity window — in the days following ketamine therapy, when the brain is still in this state of heightened flexibility — produces better outcomes than either the drug or the therapy alone. The window is when the door is open widest. What you bring through it matters.
How to Use the Window — Practically
The crying that continues in the days after a session is part of the same process as the crying during the session. It’s the neuroplasticity window still open. It’s the brain still doing its work. Let it.
The Tears Aren’t Always Grief
Here is something that surprises people, including people who have been through it: you can be crying during a ketamine session and not be sad. Not sad in any way you can identify.
Not thinking about anything sad. Not processing a loss, not revisiting a memory, not feeling the weight of the depression that brought you here. Just crying — and alongside the crying, something that doesn’t have a clean name. Not grief. Not pain. Something else.
This matters because the default interpretation most people apply to tears — including their own — is that tears mean sadness. That framework fails almost completely in the ketamine context. What patients report, consistently across qualitative research and in the accounts I hear from readers, is a much wider emotional range.
The Full Emotional Range — What Patients Actually Report
Why the Range Matters — And Why Misclassification Can Be Distressing
The range is important for patients to know about because the misclassification can be distressing. People who are crying and feeling something that isn’t sadness can become alarmed — they assume they must be concealing grief from themselves, or that the absence of an identified cause means something is wrong. Neither follows. The emotional range in a ketamine session is genuinely wider than ordinary experience, and the absence of a legible label on what you’re feeling is an expected feature of the state, not a symptom of something wrong with the experience.
You might cry and feel strangely okay at the same time.
That is not a contradiction. It may simply mean your emotional system is coming back online in a wider way than you expected.
What Providers Actually See — The Clinical Picture
Clinicians who have administered ketamine across hundreds of sessions have seen the full range. They are not surprised by the crying. The ones who know what they’re doing are not alarmed by it — and actively manage the session to make space for it rather than interrupt it.
That clinical posture is worth understanding, because what a provider does in response to a patient’s emotional release during a session can meaningfully shape whether the release moves forward or gets cut off.
How Trained Providers Frame Emotional Release
The physician account from Section 1 — the patient who hadn’t cried in twenty years, the eye mask drenched session after session — is not an anecdote a clinician shares to describe a problem. It’s one they share to describe something working. That framing is consistent across practitioner-facing guidance in this space. The clinical consensus that has formed informally, across providers who work in ketamine and psychedelic therapy, is that crying during a session is not a complication. It is the emotional processing architecture doing what the session is meant to help it do.
Clinical consensus
Provider education materials for clinicians working in ketamine therapy describe crying as emotional release integral to the therapeutic process and counsel against interrupting it. The instinct to comfort a patient who is visibly distressed — to say something, to make reassuring contact, to try to pull them back toward calm — is a natural one. It is also, in this context, often counterproductive. The crying is the thing that needs to happen. Interrupting it to manage the provider’s own discomfort with a patient’s distress is not supportive care; it’s interference.
What Trained Providers Do Instead
What the Clinical Data Shows About Emotional Experience and Outcomes
The Osmind survey of clinicians working in ketamine and psychedelic therapy found that practitioners broadly view emotional experience as integral to session outcomes — not incidental to them, not something to be minimized. The clinical picture that emerges from practitioners who do this work consistently is that sessions with significant emotional release are often, though not always, the sessions with the most meaningful clinical impact.
Why Provider Training Matters — A Practical Implication
This has a practical implication for patients choosing where to receive treatment: provider training matters here. A clinic whose staff are not prepared for emotional responses during infusions — or who are trained to manage them as adverse events rather than as process — is a different clinical environment than one that treats emotional release as part of the work. It’s a reasonable question to ask before you start.
IV vs. Spravato — Does the Route Change the Experience?
The short answer: yes, meaningfully. Not in whether emotional release happens — both routes can produce it — but in how it happens, and how intense it tends to be.
The Pharmacokinetic Difference — Where It Starts
The pharmacokinetic difference is the place to start. Intravenous ketamine delivers the drug directly into the bloodstream, which means onset is fast, peak plasma concentrations are high, and the dissociative experience is typically fuller and more immersive. The subjective experience of IV ketamine is often described as being taken somewhere — a significant departure from ordinary consciousness, with the degree of ego dissolution, altered perception, and internal experience that comes with it. That depth of altered state is correlated with deeper emotional access.
Spravato (esketamine) is delivered intranasally. Absorption through the nasal mucosa is slower and more variable than IV delivery, which means onset takes longer, peak concentrations are lower, and the overall dissociative intensity is typically more moderate. In clinical trials, dissociation occurred in 41% of patients in the esketamine plus oral antidepressant group — a real effect, but with a ceiling that most IV patients would recognize as milder. The subjective experience is more commonly described as a perceptual shift rather than a departure from consciousness — a gentler alteration of the state you’re already in.
Both Routes Document Crying — The Mechanisms Are the Same
Crying has been documented under both routes. The esketamine pharmacovigilance database found a crying reporting odds ratio of 4.78 — meaning crying was reported at nearly five times the expected rate among Spravato patients compared to patients on non-esketamine antidepressants. IV clinical data documents it directly in patient studies. The underlying mechanisms — amygdala recalibration, DMN disruption, prefrontal gating suspended, emotional memory rendered labile — are operating in both cases. The drug is the same drug. The neuropharmacology is the same neuropharmacology.
What differs is the character and intensity of the emotional experience, not whether it occurs. IV tends to produce more immersive, sometimes more intense emotional release during the session itself. Spravato tends to produce a subtler experience — one that some patients describe as easier to tolerate, and one that may feel less like being overwhelmed and more like being opened. Neither character is superior; they’re different profiles.
On the evidence
There is no head-to-head comparative data on crying specifically across routes. What is described above is the reasonable inference from pharmacokinetic differences and what each route’s dissociative profile looks like — not a direct comparison from a study that asked this question.
A Direct Note for Spravato Patients
If your sessions don’t involve intense emotional experiences — if you’re not crying, if you’re not being taken somewhere dramatic — that is normal for this route. It doesn’t mean the treatment is failing or that the mechanisms aren’t active. It means you’re getting a pharmacokinetic profile that produces a gentler version of the same underlying process. The therapeutic work is still happening. The window still opens. The bar for what counts as a “real” emotional response during ketamine therapy is not set by the IV experience.
Does Crying Mean the Treatment Is Working?
No study has directly correlated crying during ketamine therapy with treatment outcomes. That study does not exist. But the literature does show something adjacent — and meaningful.
What the Literature Actually Shows
Research on ketamine-assisted psychotherapy consistently finds that the quality of the subjective experience during the session predicts outcomes in ways that general drug intensity does not. Three bodies of evidence converge on this:
The Honest Framing
None of this directly measures crying. But it converges on something important: sessions with meaningful emotional experience tend to be associated with better outcomes than sessions without. Crying is one form of meaningful emotional experience. The absence of a direct measurement doesn’t mean the relationship doesn’t exist; it means we haven’t studied it with the precision to say so definitively.
Crying is process, not outcome.
Think of it this way: the crying is evidence that a door has opened. What you do with that open door — in the session, in the days after, in integration therapy — determines what it becomes. It is a condition that appears necessary for a certain kind of therapeutic work, not a guarantee that the work has been done.
What the Variability Actually Looks Like
The emotional texture of the session is one signal among many, and it is not the signal that overrides all others.
If you’re crying, it means the drug is doing something real to your emotional architecture. That’s not nothing. Whether it becomes everything depends on what comes next.
What If You Don’t Cry?
A meaningful minority of patients go through ketamine therapy without crying — not once, not across an entire series — and a subset of them spend the treatment worrying that this means something is wrong.
It doesn’t.
The absence of crying is not evidence that the drug isn’t working, that your emotional system is too shut down to respond, or that you’re doing the sessions incorrectly. Individual variation in emotional expression is genuine, large, and not predictive of therapeutic response. Some people process emotionally without any external expression. Some have deeply internal sessions — visual, somatic, or cognitively altered — without producing tears. Some have experiences that are profound and reorganizing and entirely quiet on the outside.
The Distinction Between Emotional Processing and Emotional Expression
There is also a distinction worth making between emotional processing and emotional expression. The mechanisms — amygdala recalibration, DMN disruption, prefrontal gating suspension, memory reconsolidation — do not require crying to be operational. They operate in patients who sob for an hour and in patients who lie still and silent through the session. The internal process can be fully active without any of it reaching the surface in the form of tears.
What the Evidence Actually Says About Non-Criers
If you’re in this group
If you’re someone who has been through sessions without crying and has been quietly wondering about it — the answer is that you are not an outlier who needs explaining. You are in a normal range of response to an experience that looks different in different people. The bar for what counts as “a real session” is not defined by the patient in the next room who sobbed through theirs.
What To Do With It — Before, During, and After
The experience of emotional release during ketamine therapy is something you can prepare for, work with during the session, and use well afterward. Most patients aren’t told any of this. Here’s what’s actually useful.
Knowing that emotional release is common, that it can be intense, and that it is not a sign something is going wrong — that knowledge alone changes how you meet it when it arrives.
Beyond that: consider setting an intention before the session. Not a demand — not I need to resolve this specific grief — but a direction. An openness. Something like: I am willing to feel what’s there. That posture matters because the instinct under emotional pressure is often the opposite — to brace, to manage, to keep it contained. Giving yourself permission in advance to not do that is worth something.
The instruction here is simple and genuinely hard to follow: don’t suppress it.
The first hours after a ketamine therapy are still part of the experience — the drug may be metabolizing, but the neuroplastic window is open and the emotional sensitivity remains elevated. Treat this time accordingly.
The neuroplasticity window doesn’t close when you walk out of the clinic. It remains open, in varying degrees, for 24 to 72 hours. During that window, the brain is more capable of forming new emotional and cognitive patterns than at almost any other point in treatment. Ordinary things will move you more than they normally do. Let them. That sensitivity is not a liability — it’s a resource.
This is when integration therapy matters most. If you have a therapist or integration practitioner, schedule a session in this window. The emotional material from the infusion is closest to the surface, the brain is most plastic, and the conditions for genuine therapeutic work are at their peak. Integration after the session is where the crying-without-knowing-why often becomes the crying-that-now-makes-sense — not because you’ve located the story, but because you’ve had space to let something reorganize.
If you’re working with a therapist who isn’t familiar with ketamine’s mechanisms, you may need to briefly explain what happened so they can help you work with it. You don’t need to deliver a neuroscience lecture. The useful frame is this:
“I cried during the session, and I don’t know why — the drug temporarily disconnects the emotional charge from the narrative, so the feeling arrived without a story. The feeling was real. I’d like help understanding what it might be pointing toward.”
Most therapists, even those unfamiliar with ketamine specifically, know how to work with emotional material that doesn’t have a clear cause. What they need from you is permission to not require that you explain the crying before they can help you with it.